The Insight Partners published latest research report on “Immunoassay Market Size Report, Trends, Share, Growth & Demand to 2027 - Global Analysis and Forecasts By Product, Technology, Application, and End User”
The Insight Partners published latest research report on “Immunoassay Market Size Report, Trends, Share, Growth & Demand to 2027 - Global Analysis and Forecasts By Product, Technology, Application, and End User”, the global market size is projected to reach USD 37,987.76 million by 2027 from USD 21,800.00 million in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00005380
Growth Strategies by the Key Players Operating in the Immunoassay Market:
November 18 - bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the acquisition of a minority stake in July 2018. Founded in 2009 and based in Suzhou (China), Hybiome is specialized in automated immunoassay tests. The company develops, manufactures and markets a complete range of diagnostic solutions cleared by the China Food and Drug Administration (CFDA).
November 16 - Siemens Healthineers has acquired Conworx Technology, a company specializing in point-of-care device interfaces and big data management, for an undisclosed sum.
May 2016 - DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics’ Molecular and Immunoassay Product Business from Quest Diagnostics
The immunoassay market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the immunoassay market are present across the globe and have wide distribution and sales network through partnerships or authorized dealers.
Traditional in vitro diagnostics (IVDs) are generally conducted in laboratories prepared with expensive equipment and staffed with trained personnel accountable for performing the tests. Since the last few decades, diagnostic testing has gradually progressed out of the central laboratory and into testing sites, which is close to patients. The point-of-care testing (POCT) enables laboratory service providers to accomplish testing at the patient’s location, facilitating disease diagnosis, monitoring, and management. Intense technological inventions in POCT have been done during the last few years. For instance, nanotechnologies significantly enhance magnetic, electrical, optical, and chemical properties, liable for improving the performance of POCT. The latest trend in point-of-care diagnostics (POCD) is tending intensely to smart devices with mobile healthcare. It could genuinely transform healthcare monitoring and management, making a new way for next-generation POCT. Therefore, these factors have increased the demand of immunoassay-based point-of-care testing for diagnostic purposes in the coming future.
Directly Purchase Premium Copy of Immunoassay Market Growth Report (2019-2027) at: https://www.theinsightpartners.com/buy/TIPRE00005380
Global Immunoassay Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 21,800.00 Million in 2018 |
| Market Size Value by | USD 37,987.76 Million by 2027 |
| Growth rate | CAGR of 6.5% from 2019 to 2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
| No. of Pages | 157 |
| No. of Tables | 96 |
| No. of Charts & Figures | 81 |
| Historical data available | Yes |
| Segments covered | Product, Technology, Application, End User and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Siemens, BD, bioMérieux SA, Abbott, F. Hoffmann La-Roche Ltd, Danaher, Ortho Clinical Diagnostics (Johnson & Johnson Services, Inc.), Sysmex Corporation, Thermo Fisher Scientific, Inc, Quidel Corporation |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 157 pages with 96 list of tables & 81 list of figures from the report, “Immunoassay Market to 2027 - Global Analysis and Forecasts By Product (Reagents & Kits, Analyzers & Instruments, and Software & Services), Technology [Enzyme-Linked Immunosorbent Assays (ELISA), Fluorescence, Chemiluminescence, Rapid Test, Western Blot, Enzyme-Linked Immune Absorbent Spot (ELISPOT), and Polymerase Chain Reaction (PCR)], Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), and End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/immunoassay-market
Global immunoassay market is segmented by product, technology, application, end user. On the basis of product, the market is segmented reagents & kits, analyzers & instruments, software & services. On the basis of technology, it is segmented into enzyme-linked immunosorbent assays (ELISA), fluorescence, chemiluminescence, rapid test, western blot, enzyme-linked immune absorbent spot (ELISPOT), polymerase chain reaction (PCR). On the basis of application, the immunoassay market is further segmented into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, others. Based on end user the market is segmented into hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, others.
Immunoassay is used to measure the concentration of small molecules such as lipids, protein, nucleic acids, etc. in solutions using antigen-antibody reactions. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Increasing incidences of infectious diseases such as HIV is the primary global public health issue. In 2018, the World Health Organization (WHO) having claimed that more than 32 million HIV people are diagnosed, out of which 770,000 people died. At the end of 2018, around 1.7 million people were reported to be newly infected globally, including 62% of adults and 54% of children. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million U.S. residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the world.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, HIV and AIDS organization (AVERT), Center for Disease Control and Prevention (CDC), National Center for Health Statistics, American Heart Association, European Union (E.U.). and others.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Lateral Flow Immunoassay Reader Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Microfluidic Immunoassay Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Automated Immunoassay Analyzers Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Chemiluminescence Immunoassay (CLIA) Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Immunoassay Instruments Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/immunoassay-market